such as EGFR or the PI3K–Akt–mTOR pathway, will lead to improved results of anticancer therapy. Moreover, at present, little is known about the outcome of gastric cancer patients after ...

The company also shared initial data from its DisTinGuish study in gastric cancer, which did not meet ... those who have experienced anti-EGFR therapy, and those with RAS wildtype tumors.

During a live event, Alexander I. Spira, MD, PhD, and participants NGS testing practices and the rationale behind their ...

Comprehensive biomarker testing can identify EGFR or other mutations in your lung cancer. Learn the benefits of testing and how it can help shape treatment.

Gastric (stomach) Cancer is one of the common cancers of digestive system in Southern India. Overall, the exact Gastric Cancer database of India is still not clear, however, it is believed that ...

Tagrisso was linked to higher cardiac risks in patients with EGFR-mutant NSCLC, including a four-fold rise in cardiac events ...

A collaborative research team from POSTECH has successfully developed a gastric cancer model using 3D bioprinting technology ...

Ocean Biomedical (OCEA) announced newly published research findings demonstrating the ability of its proprietary cancer immunotherapy ...

for the treatment of diffuse gastric cancer (DGC) and other advanced solid tumors. This marks a significant milestone as SIGX1094 is the first pipeline drug discovered using AI and organoid ...

New phase 3 data presented at ESMO earlier today suggests Tagrisso could be a major step forward in treating patients with EGFR positive non-small cell lung cancer. AstraZeneca has been ...